Recent News

• 11.26.2025 - Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
• 11.26.2025 - Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
• 11.19.2025 - ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
• 11.19.2025 - ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
• 11.19.2025 - ProPhase Labs presentation as of 11/19/2025
• 11.18.2025 - ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
• 11.18.2025 - ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
• 11.17.2025 - ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
• 11.17.2025 - ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
• 10.29.2025 - ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

Recent Filings

• 11.26.2025 - 8-K Current report
• 11.25.2025 - 8-K Current report
• 11.25.2025 - 8-K Current report
• 11.19.2025 - 8-K Current report
• 11.19.2025 - EX-99.1 EX-99.1
• 11.19.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
• 11.10.2025 - 3 Initial statement of beneficial ownership of securities
• 10.31.2025 - DEF 14A Other definitive proxy statements